Donát Alpár studied biology & chemistry and received his PhD in molecular pathology from the University of Pécs, Hungary. After serving as the head of a cancer cytogenetic laboratory for nearly five years, he spent altogether eight years at the Institute of Cancer Research (London) and at the Center for Molecular Medicine of the Austrian Academy of Sciences (Vienna). His research at the Semmelweis University focuses on the genome, epigenome and transcriptome based evolutionary scrutiny of hematological malignancies, and on the development of automated microscopy and next-generation sequencing based applications with an ultimate goal to improve cancer diagnostics and refine personalized treatment strategies.